Company intelligence / Profile preview
Jeil Pharmaceutical Co., Ltd.
Seoul, Seoul, South Koreajeilpharm.co.kr ↗
- Ownership
- Private
- Employees
- ~4999
- Development stage
- Other
01
Overview
Jeil Pharmaceutical has a long history of commercialized generic and branded pharmaceuticals across multiple therapeutic areas. Its first in-house developed new drug Jaqbo (zastaprazan citrate) was launched in 2024 for GERD after successful Phase 3 trials. The company also has clinical-stage assets like JPI‑289 for stroke and licenses/markets innovative drugs such as Fetroja® for resistant bacterial infections in South Korea
- Therapeutic areas
- GastroenterologyCardiovascularPsychiatryOncologyInfectious Diseases
- Modalities
- Small moleculeschemical drugstransdermal patchesinjectables
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
Shionogi & Co., Ltd. – partnership/licensing for Fetroja® in South KoreaTakeda Korea – co-promotion agreementLundbeck Korea – co-promotion agreement
04
Financials
- Market cap
- $92.9M
- Total revenue
- $418.4M
- Enterprise value
- $126M
Beyond the preview
Go deeper on Jeil Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jeil Pharmaceutical Co., Ltd..